Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

RECRUITING NA

Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury

NCT06841198 · View on ClinicalTrials.gov ↗

Study Summary

The study aims to explore how cardiovascular function changes in the first year after a spinal cord injury, and to see how different treatments, like spinal stimulation through the skin (transcutaneous spinal stimulation), affect blood pressure. The main questions are: How does stimulation affect blood pressure over the year? What is the level of cardiovascular activation throughout the year? The study will start during the inpatient stay at the Kessler Institute for Rehabilitation and continue after discharge as an outpatient, totaling about 20-29 sessions over the year.

Interventions

  • DEVICE spinal cord transcutaneous stimulation

Study Locations (1)

New Jersey

  • Kessler Foundation — West Orange

Trial Details

FieldValue
Enrollment Target 5 participants
Start Date 2025-04-01
Est. Completion 2026-11
Phase NA

Sponsor

Kessler Foundation

363 total trials

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06841198

The ClinicalTrials.gov registry entry for NCT06841198 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kessler Foundation, which has 363 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 4 conditions, with Spinal Cord Injuries (SCI) appearing as the primary indexed condition, and to 1 intervention — of which spinal cord transcutaneous stimulation is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT06841198 reports 1 study location spanning 1 distinct geographic area — top geographies include New Jersey. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT06841198 about?

NCT06841198 is a clinical study titled "Cardiovascular Function and Response to Stimulation Within the First Year After Spinal Cord Injury". The study aims to explore how cardiovascular function changes in the first year after a spinal cord injury, and to see how different treatments, like spinal stimulation through the skin (transcutaneous spinal stimulation), affect blood pressure. The main questions are: How does stimulation affect ...

What is the current status of trial NCT06841198?

This trial is currently recruiting. It is a NA study. The enrollment target is 5 participants. The study started on 2025-04-01. Estimated completion is 2026-11.

What conditions does trial NCT06841198 study?

This clinical trial studies the following conditions: Spinal Cord Injuries (SCI), Cardiovascular, Orthostatic Hypotension, Dysautonomic, Transcutaneous Spinal Stimulation. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT06841198?

The interventions under investigation include: spinal cord transcutaneous stimulation (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT06841198?

This trial is sponsored by Kessler Foundation, which has 363 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT06841198 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial